176 related articles for article (PubMed ID: 33437032)
1. Comprehensive study of 28 individuals with SIN3A-related disorder underscoring the associated mild cognitive and distinctive facial phenotype.
Balasubramanian M; Dingemans AJM; Albaba S; Richardson R; Yates TM; Cox H; Douzgou S; Armstrong R; Sansbury FH; Burke KB; Fry AE; Ragge N; Sharif S; Foster A; De Sandre-Giovannoli A; Elouej S; Vasudevan P; Mansour S; Wilson K; Stewart H; Heide S; Nava C; Keren B; Demirdas S; Brooks AS; Vincent M; Isidor B; Küry S; Schouten M; Leenders E; Chung WK; Haeringen AV; Scheffner T; Debray FG; White SM; Palafoll MIV; Pfundt R; Newbury-Ecob R; Kleefstra T
Eur J Hum Genet; 2021 Apr; 29(4):625-636. PubMed ID: 33437032
[TBL] [Abstract][Full Text] [Related]
2. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
[TBL] [Abstract][Full Text] [Related]
3. Witteveen-Kolk syndrome: The first patient from Turkey.
Ercoskun P; Yuce Kahraman C
Am J Med Genet A; 2021 Feb; 185(2):617-619. PubMed ID: 33142042
[TBL] [Abstract][Full Text] [Related]
4. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
5. Haploinsufficiency of the Sin3/HDAC corepressor complex member SIN3B causes a syndromic intellectual disability/autism spectrum disorder.
Latypova X; Vincent M; Mollé A; Adebambo OA; Fourgeux C; Khan TN; Caro A; Rosello M; Orellana C; Niyazov D; Lederer D; Deprez M; Capri Y; Kannu P; Tabet AC; Levy J; Aten E; den Hollander N; Splitt M; Walia J; Immken LL; Stankiewicz P; McWalter K; Suchy S; Louie RJ; Bell S; Stevenson RE; Rousseau J; Willem C; Retiere C; Yang XJ; Campeau PM; Martinez F; Rosenfeld JA; Le Caignec C; Küry S; Mercier S; Moradkhani K; Conrad S; Besnard T; Cogné B; Katsanis N; Bézieau S; Poschmann J; Davis EE; Isidor B
Am J Hum Genet; 2021 May; 108(5):929-941. PubMed ID: 33811806
[TBL] [Abstract][Full Text] [Related]
6. Is MED13L-related intellectual disability a recognizable syndrome?
Tørring PM; Larsen MJ; Brasch-Andersen C; Krogh LN; Kibæk M; Laulund L; Illum N; Dunkhase-Heinl U; Wiesener A; Popp B; Marangi G; Hjortshøj TD; Ek J; Vogel I; Becher N; Roos L; Zollino M; Fagerberg CR
Eur J Med Genet; 2019 Feb; 62(2):129-136. PubMed ID: 29959045
[TBL] [Abstract][Full Text] [Related]
7. Attention Deficit Hyperactivity and Autism Spectrum Disorders as the Core Symptoms of AUTS2 Syndrome: Description of Five New Patients and Update of the Frequency of Manifestations and Genotype-Phenotype Correlation.
Sanchez-Jimeno C; Blanco-Kelly F; López-Grondona F; Losada-Del Pozo R; Moreno B; Rodrigo-Moreno M; Martinez-Cayuelas E; Riveiro-Alvarez R; Fenollar-Cortés M; Ayuso C; Rodríguez de Alba M; Lorda-Sanchez I; Almoguera B
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573342
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic variants in
Granadillo JL; P A Stegmann A; Guo H; Xia K; Angle B; Bontempo K; Ranells JD; Newkirk P; Costin C; Viront J; Stumpel CT; Sinnema M; Panis B; Pfundt R; Krapels IPC; Klaassens M; Nicolai J; Li J; Jiang Y; Marco E; Canton A; Latronico AC; Montenegro L; Leheup B; Bonnet C; M Amudhavalli S; Lawson CE; McWalter K; Telegrafi A; Pearson R; Kvarnung M; Wang X; Bi W; Rosenfeld JA; Shinawi M
J Med Genet; 2020 Oct; 57(10):717-724. PubMed ID: 32152250
[TBL] [Abstract][Full Text] [Related]
9. Novel SIN3A mutation identified in a Japanese patient with Witteveen-Kolk syndrome.
Narumi-Kishimoto Y; Araki N; Migita O; Kawai T; Okamura K; Nakabayashi K; Kaname T; Ozawa Y; Ozawa H; Takada F; Hata K
Eur J Med Genet; 2019 Sep; 62(9):103547. PubMed ID: 30267900
[No Abstract] [Full Text] [Related]
10. Behavior and cognitive functioning in Witteveen-Kolk syndrome.
van Dongen LCM; Wingbermühle E; Dingemans AJM; Bos-Roubos AG; Vermeulen K; Pop-Purceleanu M; Kleefstra T; Egger JIM
Am J Med Genet A; 2020 Oct; 182(10):2384-2390. PubMed ID: 32783353
[TBL] [Abstract][Full Text] [Related]
11. Clinical delineation of SETBP1 haploinsufficiency disorder.
Jansen NA; Braden RO; Srivastava S; Otness EF; Lesca G; Rossi M; Nizon M; Bernier RA; Quelin C; van Haeringen A; Kleefstra T; Wong MMK; Whalen S; Fisher SE; Morgan AT; van Bon BW
Eur J Hum Genet; 2021 Aug; 29(8):1198-1205. PubMed ID: 33867525
[TBL] [Abstract][Full Text] [Related]
12. Further expanding the clinical phenotype in Bainbridge-Ropers syndrome and dissecting genotype-phenotype correlation in the ASXL3 mutational cluster regions.
Yu KP; Luk HM; Fung JLF; Chung BH; Lo IF
Eur J Med Genet; 2021 Jan; 64(1):104107. PubMed ID: 33242595
[TBL] [Abstract][Full Text] [Related]
13. Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation.
Asadollahi R; Zweier M; Gogoll L; Schiffmann R; Sticht H; Steindl K; Rauch A
Eur J Med Genet; 2017 Sep; 60(9):451-464. PubMed ID: 28645799
[TBL] [Abstract][Full Text] [Related]
14. Expanding the neurological and behavioral phenotype of White-Sutton syndrome: a case report.
Donnarumma B; Riccio MP; Terrone G; Palma M; Strisciuglio P; Scala I
Ital J Pediatr; 2021 Jul; 47(1):148. PubMed ID: 34215294
[TBL] [Abstract][Full Text] [Related]
15. De Novo Mutations of CCNK Cause a Syndromic Neurodevelopmental Disorder with Distinctive Facial Dysmorphism.
Fan Y; Yin W; Hu B; Kline AD; Zhang VW; Liang D; Sun Y; Wang L; Tang S; Powis Z; Li L; Yan H; Shi Z; Yang X; Chen Y; Wang J; Jiang Y; Tan H; Gu X; Wu L; Yu Y
Am J Hum Genet; 2018 Sep; 103(3):448-455. PubMed ID: 30122539
[TBL] [Abstract][Full Text] [Related]
16. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype.
Chilton I; Okur V; Vitiello G; Selicorni A; Mariani M; Goldenberg A; Husson T; Campion D; Lichtenbelt KD; van Gassen K; Steinraths M; Rice J; Roeder ER; Littlejohn RO; Srour M; Sebire G; Accogli A; Héron D; Heide S; Nava C; Depienne C; Larson A; Niyazov D; Azage M; Hoganson G; Burton J; Rush ET; Jenkins JL; Saunders CJ; Thiffault I; Alaimo JT; Fleischer J; Groepper D; Gripp KW; Chung WK
Am J Med Genet A; 2020 May; 182(5):962-973. PubMed ID: 32031333
[TBL] [Abstract][Full Text] [Related]
17. De Novo and Inherited Pathogenic Variants in KDM3B Cause Intellectual Disability, Short Stature, and Facial Dysmorphism.
Diets IJ; van der Donk R; Baltrunaite K; Waanders E; Reijnders MRF; Dingemans AJM; Pfundt R; Vulto-van Silfhout AT; Wiel L; Gilissen C; Thevenon J; Perrin L; Afenjar A; Nava C; Keren B; Bartz S; Peri B; Beunders G; Verbeek N; van Gassen K; Thiffault I; Cadieux-Dion M; Huerta-Saenz L; Wagner M; Konstantopoulou V; Vodopiutz J; Griese M; Boel A; Callewaert B; Brunner HG; Kleefstra T; Hoogerbrugge N; de Vries BBA; Hwa V; Dauber A; Hehir-Kwa JY; Kuiper RP; Jongmans MCJ
Am J Hum Genet; 2019 Apr; 104(4):758-766. PubMed ID: 30929739
[TBL] [Abstract][Full Text] [Related]
18. Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism.
Chopra M; McEntagart M; Clayton-Smith J; Platzer K; Shukla A; Girisha KM; Kaur A; Kaur P; Pfundt R; Veenstra-Knol H; Mancini GMS; Cappuccio G; Brunetti-Pierri N; Kortüm F; Hempel M; Denecke J; Lehman A; ; Kleefstra T; Stuurman KE; Wilke M; Thompson ML; Bebin EM; Bijlsma EK; Hoffer MJV; Peeters-Scholte C; Slavotinek A; Weiss WA; Yip T; Hodoglugil U; Whittle A; diMonda J; Neira J; Yang S; Kirby A; Pinz H; Lechner R; Sleutels F; Helbig I; McKeown S; Helbig K; Willaert R; Juusola J; Semotok J; Hadonou M; Short J; ; Yachelevich N; Lala S; Fernández-Jaen A; Pelayo JP; Klöckner C; Kamphausen SB; Abou Jamra R; Arelin M; Innes AM; Niskakoski A; Amin S; Williams M; Evans J; Smithson S; Smedley D; de Burca A; Kini U; Delatycki MB; Gallacher L; Yeung A; Pais L; Field M; Martin E; Charles P; Courtin T; Keren B; Iascone M; Cereda A; Poke G; Abadie V; Chalouhi C; Parthasarathy P; Halliday BJ; Robertson SP; Lyonnet S; Amiel J; Gordon CT
Am J Hum Genet; 2021 Jun; 108(6):1138-1150. PubMed ID: 33909992
[TBL] [Abstract][Full Text] [Related]
19. A second cohort of CHD3 patients expands the molecular mechanisms known to cause Snijders Blok-Campeau syndrome.
Drivas TG; Li D; Nair D; Alaimo JT; Alders M; Altmüller J; Barakat TS; Bebin EM; Bertsch NL; Blackburn PR; Blesson A; Bouman AM; Brockmann K; Brunelle P; Burmeister M; Cooper GM; Denecke J; Dieux-Coëslier A; Dubbs H; Ferrer A; Gal D; Bartik LE; Gunderson LB; Hasadsri L; Jain M; Karimov C; Keena B; Klee EW; Kloth K; Lace B; Macchiaiolo M; Marcadier JL; Milunsky JM; Napier MP; Ortiz-Gonzalez XR; Pichurin PN; Pinner J; Powis Z; Prasad C; Radio FC; Rasmussen KJ; Renaud DL; Rush ET; Saunders C; Selcen D; Seman AR; Shinde DN; Smith ED; Smol T; Snijders Blok L; Stoler JM; Tang S; Tartaglia M; Thompson ML; van de Kamp JM; Wang J; Weise D; Weiss K; Woitschach R; Wollnik B; Yan H; Zackai EH; Zampino G; Campeau P; Bhoj E
Eur J Hum Genet; 2020 Oct; 28(10):1422-1431. PubMed ID: 32483341
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive phenotypes of patients with SYNGAP1-related disorder reveals high rates of epilepsy and autism.
Wiltrout K; Brimble E; Poduri A
Epilepsia; 2024 May; 65(5):1428-1438. PubMed ID: 38470175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
